Handel ADMA Biologics, Inc. - ADMA CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.0282 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024068% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.001846% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Tidligere luk* | 3.0706 |
Åben* | 3.0207 |
1-Års Ændring* | 97.43% |
Dagens Spænd* | 2.9809 - 3.0806 |
52-Ugers Spænd | 1.43-3.98 |
Gennemsnitlig Volumen (10 dage) | 3.13M |
Gennemsnitlig Volumen (3 måneder) | 49.74M |
Market Cap | 675.04M |
P/E-forhold | -100.00K |
Udestående aktier | 217.76M |
Omsætning | 130.48M |
EPS | -0.37 |
Dividend (Udbytte %) | N/A |
Beta | 0.92 |
Næste indtjeningsopgørelse | Mar 23, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Mar 22, 2023 | 2.9809 | -0.0697 | -2.28% | 3.0506 | 3.0905 | 2.9809 |
Mar 21, 2023 | 3.0706 | 0.0300 | 0.99% | 3.0406 | 3.1703 | 3.0406 |
Mar 20, 2023 | 3.0507 | -0.0299 | -0.97% | 3.0806 | 3.1005 | 2.9310 |
Mar 17, 2023 | 3.0606 | -0.0298 | -0.96% | 3.0904 | 3.1204 | 3.0207 |
Mar 16, 2023 | 3.1105 | 0.0300 | 0.97% | 3.0805 | 3.1703 | 3.0506 |
Mar 15, 2023 | 3.1105 | 0.0001 | 0.00% | 3.1104 | 3.1902 | 3.0806 |
Mar 14, 2023 | 3.2002 | -0.0099 | -0.31% | 3.2101 | 3.2600 | 3.1603 |
Mar 13, 2023 | 3.1803 | 0.1696 | 5.63% | 3.0107 | 3.2201 | 3.0008 |
Mar 10, 2023 | 3.0806 | -0.1594 | -4.92% | 3.2400 | 3.2600 | 3.0307 |
Mar 9, 2023 | 3.2600 | -0.1496 | -4.39% | 3.4096 | 3.4395 | 3.2102 |
Mar 8, 2023 | 3.3896 | 0.0100 | 0.30% | 3.3796 | 3.4495 | 3.3497 |
Mar 7, 2023 | 3.3797 | 0.0200 | 0.60% | 3.3597 | 3.4495 | 3.2998 |
Mar 6, 2023 | 3.3398 | -0.0697 | -2.04% | 3.4095 | 3.4295 | 3.2999 |
Mar 3, 2023 | 3.3996 | -0.0897 | -2.57% | 3.4893 | 3.4893 | 3.3697 |
Mar 2, 2023 | 3.4395 | -0.0698 | -1.99% | 3.5093 | 3.5392 | 3.4395 |
Mar 1, 2023 | 3.5292 | -0.0099 | -0.28% | 3.5391 | 3.6489 | 3.5292 |
Feb 28, 2023 | 3.5392 | 0.0798 | 2.31% | 3.4594 | 3.5890 | 3.4594 |
Feb 27, 2023 | 3.4694 | 0.0599 | 1.76% | 3.4095 | 3.5192 | 3.3996 |
Feb 24, 2023 | 3.4096 | 0.0101 | 0.30% | 3.3995 | 3.4694 | 3.3995 |
Feb 23, 2023 | 3.4893 | -0.0100 | -0.29% | 3.4993 | 3.5192 | 3.4594 |
ADMA Biologics, Inc. Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total omsætning | 80.9426 | 42.2198 | 29.3491 | 16.9853 | 22.7606 |
Omsætning | 80.9426 | 42.2198 | 29.3491 | 16.9853 | 22.7606 |
Kost af omsætning, Total | 79.7693 | 61.2914 | 39.5042 | 42.1946 | 29.1643 |
Bruttofortjeneste | 1.17329 | -19.0716 | -10.1552 | -25.2094 | -6.40376 |
Totale Driftsudgifter | 139.316 | 106.143 | 80.7359 | 77.2742 | 63.2808 |
Salgs/Generelle/Admin. Udgifter, Total | 55.1856 | 39.2209 | 28.0804 | 30.3085 | 24.5966 |
Forskning & Udvikling | 3.64606 | 5.90701 | 2.34385 | 3.92612 | 6.22959 |
Usædvanlig Udgift (Indkomst) | 0 | -0.9918 | 9.9625 | 0 | 2.05561 |
Driftsindtægter | -58.3737 | -63.9231 | -51.3868 | -60.2889 | -40.5202 |
Renteindkomst (Udgift), Netto Ikke-Drift | -13.0223 | -11.6969 | -8.19259 | -5.32738 | -3.22862 |
Andre, Netto | -0.25158 | -0.12853 | -0.22732 | -0.12712 | -0.01014 |
Netto Indkomst Før Skat | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Netto Indkomst Efter Skat | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Netto Indkomst Før Ekstra Ting | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Netto Indkomst | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Fortyndet Netto Indkomst | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Fortyndet Vægtet Gennemsnit Aktier | 139.579 | 86.1451 | 54.3481 | 45.1889 | 22.896 |
Fortyndet EPS Uden Ekstraordinære Ting | -0.51331 | -0.87931 | -0.88833 | -1.45486 | -1.9112 |
Fortyndet Normaliseret EPS | -0.51331 | -0.89083 | -0.91713 | -1.45486 | -1.82142 |
Depreciation / Amortization | 0.71535 | 0.71535 | 0.84494 | 0.84494 | 1.23467 |
Totale Ekstraordinære Ting | 0 | ||||
Gain (Loss) on Sale of Assets | 0 | 11.5274 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total omsætning | 29.1031 | 26.3829 | 20.6805 | 17.8306 | 16.0486 |
Omsætning | 29.1031 | 26.3829 | 20.6805 | 17.8306 | 16.0486 |
Kost af omsætning, Total | 25.441 | 22.8714 | 20.2952 | 18.8326 | 17.7701 |
Bruttofortjeneste | 3.66204 | 3.51149 | 0.38534 | -1.00203 | -1.7215 |
Totale Driftsudgifter | 50.5881 | 39.5741 | 35.1176 | 33.4118 | 31.2129 |
Salgs/Generelle/Admin. Udgifter, Total | 17.6742 | 15.7948 | 13.873 | 13.2415 | 12.2763 |
Forskning & Udvikling | 0.62411 | 0.72899 | 0.77056 | 1.15887 | 0.98765 |
Depreciation / Amortization | 0.17884 | 0.17884 | 0.17884 | 0.17884 | 0.17884 |
Driftsindtægter | -21.485 | -13.1912 | -14.4371 | -15.5812 | -15.1643 |
Renteindkomst (Udgift), Netto Ikke-Drift | -3.35597 | -3.31343 | -3.29442 | -3.24075 | -3.17369 |
Andre, Netto | -0.16688 | -0.1448 | 0.01855 | -0.08332 | -0.042 |
Netto Indkomst Før Skat | -25.0079 | -16.6494 | -17.7129 | -18.9053 | -18.3799 |
Netto Indkomst Efter Skat | -25.0079 | -16.6494 | -17.7129 | -18.9053 | -18.3799 |
Netto Indkomst Før Ekstra Ting | -25.0079 | -16.6494 | -17.7129 | -18.9053 | -18.3799 |
Netto Indkomst | -25.0079 | -16.6494 | -17.7129 | -18.9053 | -18.3799 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -25.0079 | -16.6494 | -17.7129 | -18.9053 | -18.3799 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -25.0079 | -16.6494 | -17.7129 | -18.9053 | -18.3799 |
Fortyndet Netto Indkomst | -25.0079 | -16.6494 | -17.7129 | -18.9053 | -18.3799 |
Fortyndet Vægtet Gennemsnit Aktier | 195.872 | 181.267 | 133.77 | 127.416 | 115.662 |
Fortyndet EPS Uden Ekstraordinære Ting | -0.12767 | -0.09185 | -0.13241 | -0.14837 | -0.15891 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Fortyndet Normaliseret EPS | -0.09362 | -0.09185 | -0.13241 | -0.14837 | -0.15891 |
Usædvanlig Udgift (Indkomst) | 6.66994 | 0 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 208.729 | 153.741 | 85.8204 | 44.5296 | 62.3416 |
Likvider og Kortsigtede Investeringer | 51.0891 | 55.9212 | 26.7521 | 22.7549 | 43.1076 |
Likvider & Lignende | 51.0891 | 55.9212 | 26.7521 | 22.7549 | 43.1076 |
Kortsigtede Investeringer | |||||
Totale Tilgodehavender, Netto | 28.5769 | 13.2373 | 3.46992 | 1.39244 | 3.88015 |
Accounts Receivable - Trade, Net | 28.5769 | 13.2373 | 3.46992 | 1.39244 | 3.88015 |
Total Inventory | 124.724 | 81.5356 | 53.0647 | 18.6162 | 12.6282 |
Prepaid Expenses | 4.33925 | 3.04647 | 2.53359 | 1.76616 | 1.22565 |
Total Assets | 276.253 | 207.673 | 127.091 | 88.8765 | 108.019 |
Property/Plant/Equipment, Total - Net | 58.1977 | 45.8523 | 33.1413 | 30.1157 | 30.4669 |
Property/Plant/Equipment, Total - Gross | 71.4696 | 54.7162 | 38.8663 | 33.5368 | 31.7528 |
Accumulated Depreciation, Total | -13.2718 | -8.86394 | -5.72496 | -3.42103 | -1.28592 |
Other Long Term Assets, Total | 4.0674 | 2.10698 | 1.44004 | 6.69725 | 6.83155 |
Total Current Liabilities | 30.3783 | 19.9474 | 14.0279 | 9.62505 | 9.44018 |
Accounts Payable | 12.4294 | 11.0737 | 9.17459 | 5.90039 | 5.92087 |
Accrued Expenses | 16.7941 | 8.73083 | 4.71047 | 3.58182 | 3.37648 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | |||||
Other Current Liabilities, Total | 1.15482 | 0.14283 | 0.14283 | 0.14283 | 0.14283 |
Total Liabilities | 135.08 | 119.424 | 100.898 | 69.1061 | 67.6861 |
Total Long Term Debt | 94.8662 | 92.9689 | 83.1992 | 44.075 | 42.9709 |
Long Term Debt | 94.8662 | 92.9689 | 83.1992 | 44.075 | 42.9709 |
Other Liabilities, Total | 9.8356 | 6.50774 | 3.67047 | 15.406 | 15.275 |
Total Equity | 141.173 | 88.2494 | 26.1931 | 19.7704 | 40.3328 |
Common Stock | 0.01958 | 0.01049 | 0.00593 | 0.00464 | 0.00453 |
Additional Paid-In Capital | 553.266 | 428.704 | 290.904 | 236.203 | 191.022 |
Retained Earnings (Accumulated Deficit) | -412.113 | -340.465 | -264.717 | -216.437 | -150.694 |
Total Liabilities & Shareholders’ Equity | 276.253 | 207.673 | 127.091 | 88.8765 | 108.019 |
Total Common Shares Outstanding | 195.814 | 104.903 | 59.3184 | 46.3531 | 36.7255 |
Other Current Assets, Total | 0 | 1.5 | |||
Goodwill, Net | 3.52951 | 3.52951 | 3.52951 | 3.52951 | 3.52951 |
Intangibles, Net | 1.72877 | 2.44412 | 3.15947 | 4.00441 | 4.84935 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 239.8 | 208.729 | 174.785 | 171.355 | 177.277 |
Likvider og Kortsigtede Investeringer | 69.505 | 51.0891 | 34.4106 | 42.409 | 61.9657 |
Likvider & Lignende | 69.505 | 51.0891 | 34.4106 | 42.409 | 61.9657 |
Totale Tilgodehavender, Netto | 25.6296 | 28.5769 | 20.3926 | 23.5446 | 15.362 |
Accounts Receivable - Trade, Net | 25.6296 | 28.5769 | 20.3926 | 23.5446 | 15.362 |
Total Inventory | 139.146 | 124.724 | 114.123 | 99.6997 | 94.1462 |
Prepaid Expenses | 5.5193 | 4.33925 | 5.85905 | 5.70186 | 5.80261 |
Total Assets | 308.033 | 276.253 | 238.64 | 232.814 | 235.667 |
Property/Plant/Equipment, Total - Net | 60.3271 | 58.1977 | 55.0847 | 53.316 | 50.3729 |
Property/Plant/Equipment, Total - Gross | 75.0076 | 71.4696 | 67.2809 | 64.2715 | 60.2769 |
Accumulated Depreciation, Total | -14.6804 | -13.2718 | -12.1962 | -10.9555 | -9.90401 |
Goodwill, Net | 3.52951 | 3.52951 | 3.52951 | 3.52951 | 3.52951 |
Intangibles, Net | 1.54993 | 1.72877 | 1.90761 | 2.08645 | 2.26528 |
Other Long Term Assets, Total | 2.82575 | 4.0674 | 3.33351 | 2.52666 | 2.22278 |
Total Current Liabilities | 31.5665 | 30.3783 | 32.3372 | 18.1864 | 21.2057 |
Accounts Payable | 14.1151 | 12.4294 | 17.2828 | 6.16747 | 12.1529 |
Accrued Expenses | 14.2198 | 16.7941 | 13.0301 | 10.7303 | 8.14151 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 3.23159 | 1.15482 | 2.02432 | 1.28866 | 0.91137 |
Total Liabilities | 181.099 | 135.08 | 135.86 | 121.22 | 123.163 |
Total Long Term Debt | 138.423 | 94.8662 | 94.363 | 93.877 | 93.4127 |
Long Term Debt | 138.423 | 94.8662 | 94.363 | 93.877 | 93.4127 |
Other Liabilities, Total | 11.1099 | 9.8356 | 9.15999 | 9.15685 | 8.54454 |
Total Equity | 126.933 | 141.173 | 102.78 | 111.594 | 112.504 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.01964 | 0.01958 | 0.01383 | 0.01319 | 0.0123 |
Additional Paid-In Capital | 564.034 | 553.266 | 498.23 | 489.331 | 471.337 |
Retained Earnings (Accumulated Deficit) | -437.121 | -412.113 | -395.463 | -377.75 | -358.845 |
Total Liabilities & Shareholders’ Equity | 308.033 | 276.253 | 238.64 | 232.814 | 235.667 |
Total Common Shares Outstanding | 196.348 | 195.814 | 138.314 | 131.872 | 123.045 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Likvider Fra Driftsaktiviteter | -112.369 | -102.003 | -76.1935 | -62.6787 | -37.2718 |
Likvider Fra Driftsaktiviteter | 5.4955 | 3.94229 | 3.25815 | 3.4464 | 2.6923 |
Ikke-Likvide Ting | 5.46355 | 3.58462 | 2.33044 | 3.30681 | 4.07714 |
Likvid Rente Betalt | 11.1595 | 10.2676 | 8.11223 | 4.39997 | 2.29359 |
Ændringer i Driftskapital | -51.6804 | -33.7813 | -33.5028 | -3.68844 | -0.28224 |
Likvider fra Investeringsaktiviteter | -13.5113 | -12.7247 | -3.81184 | -2.0956 | 15.2139 |
Kapitaludgifter | -13.5113 | -12.7267 | -3.81184 | -2.0956 | -2.67633 |
Andre Investerings-Cash-Flow-Ting, Total | 0 | 0.002 | 0 | 17.8902 | |
Likvider fra Financieringsaktiviteter | 121.048 | 143.897 | 80.0026 | 42.9216 | 60.7506 |
Financiering af Cash-Flow-Ting | -0.0616 | -0.83 | -10.9395 | 0 | -3.44017 |
Udstedelse (Pensionering) af Aktier, Netto | 121.144 | 131.209 | 48.4721 | 42.9578 | 39.2074 |
Udstedelse (Pensionering) af Gæld, Netto | -0.0343 | 13.5179 | 42.47 | -0.03628 | 24.9834 |
Netto Ændring i Likviditet | -4.83203 | 29.169 | -0.00272 | -21.8527 | 38.6927 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -25.0079 | -71.6476 | -54.9982 | -37.2852 | -18.3799 |
Cash From Operating Activities | -26.0134 | -112.369 | -78.9037 | -65.4914 | -33.2291 |
Cash From Operating Activities | 1.59022 | 5.4955 | 3.97779 | 2.55562 | 1.22963 |
Non-Cash Items | 8.86246 | 5.46355 | 3.64236 | 2.50146 | 1.19026 |
Cash Interest Paid | 2.52599 | 11.1595 | 8.34697 | 5.53428 | 2.75196 |
Changes in Working Capital | -11.4582 | -51.6804 | -31.5257 | -33.2632 | -17.2691 |
Cash From Investing Activities | -2.84209 | -13.5113 | -9.8354 | -7.04674 | -2.57116 |
Capital Expenditures | -2.84209 | -13.5113 | -9.8354 | -7.04674 | -2.57116 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
Cash From Financing Activities | 47.2713 | 121.048 | 67.2286 | 59.0259 | 41.8448 |
Financing Cash Flow Items | -4.46973 | -0.0616 | -0.0616 | -0.05931 | -0.05931 |
Issuance (Retirement) of Stock, Net | 0 | 121.144 | 67.3157 | 59.1021 | 41.9125 |
Issuance (Retirement) of Debt, Net | 51.7411 | -0.0343 | -0.02551 | -0.01686 | -0.00836 |
Net Change in Cash | 18.4158 | -4.83203 | -21.5106 | -13.5122 | 6.04456 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.1941 | 13488055 | 1946140 | 2022-12-31 | LOW |
Perceptive Advisors LLC | Private Equity | 5.465 | 11900255 | 966868 | 2022-12-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.0548 | 11007209 | 1583787 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.9762 | 10835875 | 1545176 | 2022-12-31 | LOW |
NWQ Investment Management Company, LLC | Investment Advisor/Hedge Fund | 4.8736 | 10612600 | 3727960 | 2021-12-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 3.9073 | 8508409 | 2664613 | 2022-12-31 | MED |
Stonepine Capital Management, LLC | Investment Advisor/Hedge Fund | 3.1871 | 6940000 | 1940000 | 2022-12-31 | MED |
Magnetar Capital Partners LP | Investment Advisor/Hedge Fund | 2.8414 | 6187316 | 1815908 | 2022-12-31 | HIGH |
AWM Investment Company, Inc. | Investment Advisor/Hedge Fund | 2.7623 | 6015000 | 1000000 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 2.4324 | 5296781 | 3569778 | 2022-12-31 | HIGH |
Nuveen Asset Management, LLC | Investment Advisor/Hedge Fund | 1.8845 | 4103514 | -883582 | 2022-12-31 | LOW |
Velan Capital Investment Management LP | Investment Advisor/Hedge Fund | 1.8369 | 4000000 | -1269155 | 2022-12-31 | MED |
Invesco Advisers, Inc. | Investment Advisor | 1.7886 | 3894678 | 813693 | 2022-12-31 | LOW |
Aisling Capital, LLC | Private Equity | 1.6604 | 3615671 | 0 | 2022-04-15 | |
Nuveen LLC | Pension Fund | 1.5839 | 3448993 | -267644 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5553 | 3386852 | 100723 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.364 | 2970124 | 1530127 | 2022-12-31 | HIGH |
Altium Capital Management LP | Investment Advisor/Hedge Fund | 1.318 | 2870000 | -13710 | 2022-12-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 1.2959 | 2821903 | 558990 | 2022-12-31 | MED |
Caligan Partners, LP | Hedge Fund | 1.2289 | 2676093 | -8217144 | 2022-12-31 | MED |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ADMA Biologics, Inc. Company profile
Om ADMA Biologics, Inc.
ADMA Biologics, Inc. er en biofarmaceutisk virksomhed. Virksomheden udvikler, fremstiller og markedsfører specialiserede plasmabaserede biologiske lægemidler til behandling og forebyggelse af smitsomme sygdomme. Virksomheden beskæftiger sig med udvikling og kommercialisering af human plasma og plasmaafledte terapeutika. Virksomhedens patienter omfatter immunsvækkede personer, der lider af en underliggende immundefekt sygdom og er immunsupprimeret af medicinske årsager. Virksomhedens produktkandidater omfatter BIVIGAM, et intravenøst immunglobulinprodukt (IVIG) til behandling af primær humoral immundefekt (PI), ASCENIV, et IVIG-produkt til behandling af PI, og Nabi-HB, der er indiceret til behandling af akut eksponering for blod indeholdende hepatitis B-overfladeantigen (HBsAg). Dets datterselskab ADMA BioCenters driver faciliteter til indsamling af kildeplasma i USA. Dets segment Plasma Collection Centers leverer en del af sit blodplasma til fremstilling af sine produktkandidater.
Industry: | Biopharmaceuticals |
C/O Adma Biologics, Inc.
465 State Route 17
RAMSEY
NEW JERSEY 07446
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com